Candel Therapeutics, Inc. (CADL)
11.58
-0.58
(-4.81%)
USD |
NASDAQ |
Sep 10, 12:27
Candel Therapeutics Market Cap : 881.83M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 926.36M |
| September 08, 2026 | 959.09M |
| September 04, 2026 | 972.79M |
| September 03, 2026 | 987.25M |
| September 02, 2026 | 1.005B |
| September 01, 2026 | 978.12M |
| August 31, 2026 | 994.87M |
| August 28, 2026 | 994.87M |
| August 27, 2026 | 1.047B |
| August 26, 2026 | 1.011B |
| August 25, 2026 | 1.035B |
| August 24, 2026 | 978.88M |
| August 21, 2026 | 999.43M |
| August 20, 2026 | 940.06M |
| August 19, 2026 | 1.028B |
| August 18, 2026 | 917.23M |
| August 17, 2026 | 925.60M |
| August 14, 2026 | 892.11M |
| August 13, 2026 | 898.20M |
| August 12, 2026 | 812.94M |
| August 11, 2026 | 810.66M |
| August 10, 2026 | 799.24M |
| August 07, 2026 | 775.80M |
| August 06, 2026 | 775.07M |
| August 05, 2026 | 766.28M |
| Date | Value |
|---|---|
| August 04, 2026 | 769.94M |
| August 03, 2026 | 737.71M |
| July 31, 2026 | 733.31M |
| July 30, 2026 | 723.06M |
| July 29, 2026 | 688.62M |
| July 28, 2026 | 709.14M |
| July 27, 2026 | 729.65M |
| July 24, 2026 | 700.35M |
| July 23, 2026 | 722.32M |
| July 22, 2026 | 739.17M |
| July 21, 2026 | 748.70M |
| July 20, 2026 | 701.08M |
| July 17, 2026 | 745.77M |
| July 16, 2026 | 694.48M |
| July 15, 2026 | 706.21M |
| July 14, 2026 | 723.06M |
| July 13, 2026 | 706.21M |
| July 10, 2026 | 695.22M |
| July 09, 2026 | 724.52M |
| July 08, 2026 | 723.79M |
| July 07, 2026 | 721.59M |
| July 06, 2026 | 734.78M |
| July 02, 2026 | 720.13M |
| July 01, 2026 | 723.79M |
| June 30, 2026 | 754.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.739B |
| Alnylam Pharmaceuticals, Inc. | 33.43B |
| Anika Therapeutics, Inc. | 277.56M |
| Savara, Inc. | 1.093B |
| Vericel Corp. | 1.951B |
Market Cap Related Metrics
| PEG Ratio | -0.0781 |
| Price to Book Value | 6.991 |
| Price | 11.58 |
| Earnings Yield | -12.17% |
| PEGY Ratio | -0.0781 |